Citation Impact
1 from Science/Nature 56 standout
Citing Papers
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Urease-powered nanobots for radionuclide bladder cancer therapy
2024 Standout
Works of A. Ambrosetti being referenced
Investigation of receptor radionuclide therapy with 177Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index
2018
Treatment with the Radiolabelled Somatostatin Analog <sup>177</sup>Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
2013
Author Peers
| Author | Oncology | Genetics | Neurology | Epidemiology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| A. Ambrosetti | 250 | 96 | 249 | 266 | 18 | 509 | |
| Rafael Lopes Oliveira | 11 | 141 | |||||
| Lekh Nath S. Gautam | 10 | 6 | 11 | 404 | |||
| Joshua Tan | 1 | 2 | 11 | 140 | |||
| K. Yamagami | 157 | 57 | 50 | 71 | 11 | 2.6k | |
| Mark Winter | 18 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...